Retrospective Analysis of the Clinical Characteristics of Patients with Breast Cancer Treated with Telomerase Peptide Immunotherapy Combined with Cytotoxic Chemotherapy

MLA

Kim JY, et al. “Retrospective Analysis of the Clinical Characteristics of Patients with Breast Cancer Treated with Telomerase Peptide Immunotherapy Combined with Cytotoxic Chemotherapy.” Breast Cancer: Targets and Therapy, vol. ume 15, Dec. 2023, pp. 955–66. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.393955e25db54ed4b47516043fb7d7ff&authtype=sso&custid=ns315887.

APA

Kim JY, Yang DW, Kim S, & Choi JG. (2023). Retrospective Analysis of the Clinical Characteristics of Patients with Breast Cancer Treated with Telomerase Peptide Immunotherapy Combined with Cytotoxic Chemotherapy. Breast Cancer: Targets and Therapy, ume 15, 955–966.

Chicago

Kim JY, Yang DW, Kim S, and Choi JG. 2023. “Retrospective Analysis of the Clinical Characteristics of Patients with Breast Cancer Treated with Telomerase Peptide Immunotherapy Combined with Cytotoxic Chemotherapy.” Breast Cancer: Targets and Therapy ume 15 (December): 955–66. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.393955e25db54ed4b47516043fb7d7ff&authtype=sso&custid=ns315887.